Outlook Therapeutics, Inc. · NASDAQ:OTLK

GMS VENTURES & INVESTMENTS reported a 50.30% stake in Outlook Therapeutics, Inc. (Schedule 13D/A)

Event May 27, 2025 · Filed May 28, 2025

GMS VENTURES & INVESTMENTS reported a 50.30% stake in Outlook Therapeutics, Inc., 29,040,929 shares, with active intent on May 27, 2025. Filed May 28, 2025 (Schedule 13D/A).

Stake
50.30%
Shares
29,040,929
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
GMS VENTURES & INVESTMENTS50.30%29,040,929
SUKHTIAN GHIATH M.50.30%29,040,929

Source

View original at SEC

Related